Improved survival for patients with clinically T1/T2, no tongue tumors undergoing a prophylactic neck dissection

Citation
Kj. Haddadin et al., Improved survival for patients with clinically T1/T2, no tongue tumors undergoing a prophylactic neck dissection, HEAD NECK, 21(6), 1999, pp. 517-525
Citations number
31
Categorie Soggetti
Otolaryngology
Journal title
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
ISSN journal
10433074 → ACNP
Volume
21
Issue
6
Year of publication
1999
Pages
517 - 525
Database
ISI
SICI code
1043-3074(199909)21:6<517:ISFPWC>2.0.ZU;2-8
Abstract
Background. Prophylactic surgical treatment of the neck in "early tongue tu mors" is a controversial issue. Methods. From a database of 226 patients with squamous cell carcinoma of th e tongue treated at Canniesburn Hospital, Glasgow, U.K., between 1980 and 1 996, a total of 137 patients with a minimum follow up of 24 months or until death were clinically identified as being T1/T2, ND (UICC) when first seen . These patients were divided into three groups according to the management of the neck; 53 patients did not have a neck dissection at any time (NKDO) , 47 patients underwent a synchronous neck dissection at the time of treatm ent of the primary (NKDS), and 37 patients subsequently required a metachro nous neck dissection when lymph node metastasis became clinically apparent (NKDM). These three groups were compared with respect to age, sex, site, du ration of symptoms, previous treatment (if any), initial treatment protocol , resection margin, type of neck dissection (if any), loco-regional recurre nce, systemic escape, number of positive lymph nodes, and presence of extra capsular spread. Disease-related survival was calculated using Kaplan-Meier survival curves with logrank test and chi-square statistical analysis. Results. The pT stage was upgraded to T3/4 in 3/53 patients (6%) of the NKD 0 group, 11/47 patients (23%) of the NKDS group, and 2/37 patients (5%) of the NKDM group (p < 0.001). The 5-year determinate survival rates for the t hree groups were: NKDO 59.7%, NKDS 80.5%, NKDM 44.8%, and (NKDO + NKDM) 53. 6% with a statistically significant improvement in survival for NKDS vs NKD M (logrank 10.58, p = 0.001) and for NKDS vs (NKDO + NKDM) (logrank 6.06, p = 0.014). The incidences of positive nodes in the NKDS and NKDM groups wer e 18/47 patients (38%) and 32/37 patients (86%) respectively. Neck positive patients in the NKDM group had a significantly greater number of positive nodes in comparison with N positive patients in the NKDS group (chi trend, p = 0.001), a higher incidence of extracapsular spread, 30/32 vs 9/18 (chi test, p < 0.0001), and decreased survival. The incidence of occult cervical metastasis for the whole group was 41%. Conclusion. Patients with clinical T1/2, NO tongue tumors who underwent a s ynchronous neck dissection had an improved survival outcome even though as a group they had a higher incidence of occult metastasis, relatively more T 2 lesions, a worse pT stage, and had more posterior third lesions requiring more difficult initial surgery. Tongue tumors have a high incidence of sub clinical nodal disease, which is less curable when it presents clinically. The information gleaned from the nodal status allows a more informed plan o f adjuvant therapy. (C) 1999 John Wiley & Sons, Inc.